NGL Fine-Chem Limited (BOM:524774)
India · Delayed Price · Currency is INR 2,404.35
+72.40 (3.10%)
At close: Mar 6, 2026
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 14.85 billion as of March 6, 2026. Its market cap has increased by 94.65% in one year.
Market Cap
14.85B
Enterprise Value
15.18B
Revenue
4.47B
Ranking
n/a
PE Ratio
42.00
Stock Price
2,404.35
Market Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 14.85B, an increase of 18,375.29%. That is a compound annual growth rate of 27.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 14.85B | 70.64% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sudeep Pharma | 67.37B |
| Shilpa Medicare | 61.77B |
| Gujarat Themis Biosyn | 31.37B |
| Suven Life Sciences | 31.09B |
| IOL Chemicals and Pharmaceuticals | 20.92B |
| Bajaj HealthCare | 10.14B |
| Shree Ganesh Remedies | 6.37B |
| Anlon Healthcare | 5.93B |